Skip to main content

Video: Jim Cramer Reacts to Novartis' Acquisition of AveXis

Novartis agreed to acquire AveXis for $8.7 billion on Monday. TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer reacts.
  • Author:
  • Publish date:

Novartis (NVS) - Get Novartis AG Report agreed to acquire AveXis (AVXS) for $8.7 billion on Monday. 

"This is squarely in the crosshairs of Biogen (BIIB) - Get Biogen Inc. Report which has that great deal with Ionis (IONS) - Get Ionis Pharmaceuticals, Inc. Report ," said TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.

Want exclusive investing insight from Jim Cramer? Get 24/7 access to Jim's charitable trust portfolio with a free trial to Action Alerts PLUS!

Scroll to Continue

TheStreet Recommends

Watch all of Jim Cramer's full NYSE live shows right here: